Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Datapulse Technology says ACRA rejects extension request for FY2026 AGM, annual return filing

Datapulse Technology says ACRA rejects extension request for FY2026 AGM, annual return filing

BitgetBitget2026/10/06 13:04

ACRA rejected Datapulse Technology’s request to extend deadlines for holding its FY2026 AGM and filing its annual return. Regulator instructed the company to convene the AGM and lodge the annual return as soon as practicable. Datapulse plans to appeal to ACRA for reconsideration of the rejected extension applications. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Datapulse Technology Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: HIYDQW4CUUIT9PB0) on October 06, 2026, and is solely responsible for the information contained therein.

  • ACRA rejected Datapulse Technology’s request to extend deadlines for holding its FY2026 AGM and filing its annual return.
  • Regulator instructed the company to convene the AGM and lodge the annual return as soon as practicable.
  • Datapulse plans to appeal to ACRA for reconsideration of the rejected extension applications.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Datapulse Technology Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: HIYDQW4CUUIT9PB0) on October 06, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21